No Data
Express News | Pulse Biosciences announced the end of its stock rights offering.
Pulse Biosciences, Inc. Announces the Closing of Its Rights Offering
HAYWARD, Calif.--(BUSINESS WIRE)--Jul. 3, 2024--Pulse Biosciences, Inc. (Nasdaq: PLSE) (the "Company" or "Pulse Biosciences"), a company leveraging its novel and proprietary CellFX Nanosecond Pulsed F
Pulse Biosciences Received Basic Subscriptions and Over-Subscriptions in Excess of $83M >PLSE
Pulse Biosciences Received Basic Subscriptions and Over-Subscriptions in Excess of $83M >PLSE
Express News | Pulse Biosciences Inc: Oversubscribed Offering Expected to Generate $60 Mln in Immediate Proceeds
Express News | Pulse Biosciences Inc - Warrants Could Generate up to $66 Million
Pulse Biosciences, Inc. Announces Preliminary Results for Its Rights Offering
Oversubscribed offering expected to generate $60 million in immediate gross proceeds for the Company Warrants issued in the offering could generate up to an additional $66MM HAYWARD, Calif.--(BUSINESS